Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 435983, 13 pages
http://dx.doi.org/10.1155/2014/435983
Review Article

Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go

1Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain
2GRETNHE, Programa de Recerca en Càncer, Institut Hospital del Mar d’Investigacions Mèdiques, Doctor Aiguader 88, 08003 Barcelona, Spain
3Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain

Received 13 March 2014; Accepted 22 April 2014; Published 22 May 2014

Academic Editor: Ana Eugenia Rodríguez-Vicente

Copyright © 2014 Anna Puiggros et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [50 citations]

The following is the list of published articles that have cited the current article.

  • Sim Leng Tien, Fiona Pui San Liaw, Lai Ching Lau, Alvin Soon Tiong Lim, Tse Hui Lim, and Geok Yee Lee, “CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in ,” International Journal Of Hematology, vol. 100, no. 6, pp. 545–553, 2014. View at Publisher · View at Google Scholar
  • Jutta Jenderny, Claudia Goldmann, Rebekka Thede, Monika Ebrecht, and Frank Korioth, “Detection of Clonal Aberrations by Cytogenetic Analysis after Different Culture Methods and by FISH in 129 Patients with Chronic Lymphocytic Leukemia,” Cytogenetic And Genome Research, vol. 144, no. 3, pp. 163–168, 2014. View at Publisher · View at Google Scholar
  • Patricia K. A. Mongini, Rashmi Gupta, Erin Boyle, Jennifer Nieto, Hyunjoo Lee, Joanna Stein, Jela Bandovic, Tatjana Stankovic, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Charles C. Chu, and Nicholas Chiorazzi, “TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells,” Journal Of Immunology, vol. 195, no. 3, pp. 901–923, 2015. View at Publisher · View at Google Scholar
  • Marc De Braekeleer, Nadia Guéganic, Corine Tous, Marie-Josée Le Bris, Audrey Basinko, Frédéric Morel, and Nathalie Douet-Guilbert, “JUMPING TRANSLOCATION INVOLVING 13q34 IN CHRONIC LYMPHOCYTIC LEUKEMIA: REPORT OF THE FIRST CASE STUDIED BY FLUORESCENT IN SITU HYBRIDIZATION,” Leukemia & Lymphoma, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Isabel González-Gascón y Marín, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Carmen Sanzo, Anna Aventín, Anna Puiggros, Rosa Collado, Cecilia Heras, Carolina Muñoz, Julio Delgado, Margarita Ortega, María-Teresa González, Isabel Marugán, Ignacio de la Fuente, Isabel Recio, Francesc Bosch, Blanca Espinet, Marcos González, Jesús-María Hernández-Rivas, and José-Ángel Hernández, “A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia,” Hematological Oncology, 2015. View at Publisher · View at Google Scholar
  • Navrkalová, Kantorová, Jarošová, and Pospíšilová, “Molecular prognostic markers and their clinical relevance in chronic lymphocytic Leukemia,” Klinicka Onkologie, vol. 28, pp. S6–3S15, 2015. View at Publisher · View at Google Scholar
  • Chadi Nabhan, Gordana Raca, and Lynn Wang, “Predicting prognosis in chronic lymphocytic leukemia in the contemporary era,” JAMA Oncology, vol. 1, no. 7, pp. 965–974, 2015. View at Publisher · View at Google Scholar
  • Susan O'Brien, Jeffrey A Jones, Steven E Coutre, Anthony R Mato, Peter Hillmen, Constantine Tam, Anders Österborg, Tanya Siddiqi, Michael J Thirman, Richard R Furman, Osman Ilhan, Michael J Keating, Timothy G Call, Jennifer R Brown, Michelle Stevens-Brogan, Yunfeng Li, Fong Clow, Danelle F James, Alvina D Chu, Michael Hallek, and Stephan Stilgenbauer, “Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study,” The Lancet Oncology, 2016. View at Publisher · View at Google Scholar
  • P. J. Holmes, S. C. Peiper, G. K. Uppal, J. Z. Gong, Z.-X. Wang, and R. Bajaj, “Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma,” International Journal of Laboratory Hematology, 2016. View at Publisher · View at Google Scholar
  • Eyad Alhourani, Rouben Aroutiounian, Beate Pohle, Thomas Liehr, Tigran Harutyunyan, Anita Glaser, and Cordula Schlie, “Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia–Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears,” Journal of Histochemistry and Cytochemistry, vol. 64, no. 8, pp. 495–501, 2016. View at Publisher · View at Google Scholar
  • Patryk Gorniak, Bozena Budziszewska, Bartosz Pula, Maja Wasylecka, Katarzyna Borg, Grazyna Nowak, Hanna Makuch-Lasica, Ewa Lech-Maranda, Krzysztof Warzocha, and Przemyslaw Juszczynski, “Increased expression of E3 ubiquitin ligases targeting p53 in CLL patients with wild-type TP53 exhibits associations with clinical features of the dis,” Leukemia & Lymphoma, vol. 57, no. 6, pp. 1471–1473, 2016. View at Publisher · View at Google Scholar
  • Gao, “A network approach predicts NFKBIA and BIRC3 as pathogenic genes in childhood asthma,” Genetics and Molecular Research, vol. 15, no. 2, 2016. View at Publisher · View at Google Scholar
  • Eyad Alhourani, Moneeb A. K. Othman, Joana B. Melo, Isabel M. Carreira, Beata Grygalewicz, Dragana Vujic, Zeljko Zecevic, Gordana Joksic, Anita Glaser, Beate Pohle, Cordula Schlie, Sven Hauke, and Thomas Liehr, “BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients,” Oncology Letters, vol. 11, no. 5, pp. 3240–3246, 2016. View at Publisher · View at Google Scholar
  • Audrey Mohr, Yves Renaudineau, Cristina Bagacean, Jacques-Olivier Pers, Christophe Jamin, and Anne Bordron, “Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia,” OncoImmunology, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Je-Hwan Lee, Dong Soon Lee, Byungjin Hwang, Si Nae Park, Sunghoon Huh, Kyongok Im, JooRyung Huh, Jung-Ah Kim, Duhee Bang, Sungbin Choi, Hye Yoon Chung, and Eul-Ju Seo, “Genomic profile of chronic lymphocytic leukemia in Korea identified by targeted sequencing,” PLoS ONE, vol. 11, no. 12, 2016. View at Publisher · View at Google Scholar
  • Nofar Yedid, Yael Kalma, Ami Amit, Michal Caspi, Rina Rosin-Arbesfeld, Mira Malcov, Revital Kariv, and Dalit Ben-Yosef, “The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells,” BMC Cancer, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yohei Chiba, Seiya Sato, Hiroaki Itamochi, Yasuko Suga, Tomoyuki Fukagawa, Nao Oumi, Tetsuro Oishi, Tasuku Harada, Tamotsu Sugai, and Toru Sugiyama, “Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRAS,” Human Cell, vol. 30, no. 2, pp. 140–148, 2016. View at Publisher · View at Google Scholar
  • Krzysztof Lewandowski, Michał Gniot, Maria Lewandowska, Anna Wache, Błażej Ratajczak, Anna Czyż, Małgorzata Jarmuż-Szymczak, and Mieczysław Komarnicki, “B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib,” Case Reports in Medicine, vol. 2016, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • P. S. Kadam Amare, S. Kakade, K. Chopra, M. Sengar, H. Menon, H. Jain, B. Bagal, P. G. Subramanian, and S. Gujral, “Comprehensive Genetic Analysis by Integration of Conventional Karyotyping and Interphase FISH Helps Refinement of Biological Subclasses with Clinical Impact in Chronic Lymphocytic Leukemia,” Journal of Cancer Therapy, vol. 07, no. 06, pp. 427–438, 2016. View at Publisher · View at Google Scholar
  • Jennifer A. Tooze, Eita Hamzic, Fenella Willis, and Ruth Pettengell, “Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.,” Cancer Genetics, 2017. View at Publisher · View at Google Scholar
  • Nadiia Bilous, Iryna Abramenko, Vladimir Saenko, Anatoliy Chumak, Iryna Dyagil, Zoya Martina, and Iryna Kryachok, “Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia,” Leukemia Research, vol. 58, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Arantza Onaindia, L Jeffrey Medeiros, and Keyur P Patel, “Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms,” Modern Pathology, 2017. View at Publisher · View at Google Scholar
  • Yu Zheng, Xiaoyang Li, Lydia C. Manor, Hongbao Cao, and Qiusheng Chen, “An Integrative Computational Approach to Evaluate Genetic Markers for Chronic Lymphocytic Leukemia,” Journal of Computational Biology, 2017. View at Publisher · View at Google Scholar
  • Małgorzata Rogalińska, Paweł Góralski, Paweł Robak, Zofia M. Kilianska, Jerzy Z. Błoński, Jan Barciszewski, Aneta Koceva-Chyła, Henryk Piekarski, and Tadeusz Robak, “Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development,” Oncology Letters, vol. 13, no. 4, pp. 2079–2084, 2017. View at Publisher · View at Google Scholar
  • Wojciech Labaj, Anna Papiez, Andrzej Polanski, and Joanna Polanska, “Comprehensive Analysis of MILE Gene Expression Data Set Advances Discovery of Leukaemia Type and Subtype Biomarkers,” Interdisciplinary Sciences: Computational Life Sciences, vol. 9, no. 1, pp. 24–35, 2017. View at Publisher · View at Google Scholar
  • Christos K. Kontos, Sotirios G. Papageorgiou, Marios A. Diamantopoulos, Andreas Scorilas, Efthimia Bazani, Diamantina Vasilatou, Konstantinos Gkontopoulos, Eirini Glezou, Georgia Stavroulaki, George Dimitriadis, and Vasiliki Pappa, “mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia,” Leukemia Research, vol. 53, pp. 65–73, 2017. View at Publisher · View at Google Scholar
  • Richa Sinha, and William Ken Redekop, “Cost-Effectiveness of Ibrutinib Compared With Obinutuzumab With Chlorambucil in Untreated Chronic Lymphocytic Leukemia Patients With Comorbidities in the United Kingdom,” Clinical Lymphoma Myeloma and Leukemia, 2017. View at Publisher · View at Google Scholar
  • Bryone J. Kuss, and Constantine S. Tam, “Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia,” Internal Medicine Journal, vol. 47, pp. 5–10, 2017. View at Publisher · View at Google Scholar
  • Sylvain Thierry, Wael Jdey, Solana Alculumbre, Vassili Soumelis, Patricia Noguiez-Hellin, and Marie Dutreix, “The DNA repair inhibitor Dbait is specific for malignant hematologic cells in blood,” Molecular Cancer Therapeutics, vol. 16, no. 12, pp. 2817–2827, 2017. View at Publisher · View at Google Scholar
  • Cristina Bagacean, Christelle Le Dantec, Christian Berthou, Adrian Tempescul, Hussam Saad, Anne Bordron, Mihnea Zdrenghea, Victor Cristea, Nathalie Douet-Guilbert, and Yves Renaudineau, “Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion,” Clinical Epigenetics, vol. 9, no. 1, 2017. View at Publisher · View at Google Scholar
  • Svitlana V. Andreieva, Kateryna V. Korets, and Olena G. Alkhimova, “Chromosomal abnormalities in bone marrow cells in relapse of chronic lymphocytic leukemia,” The Nucleus, 2017. View at Publisher · View at Google Scholar
  • Alain Mina, Jose Sandoval Sus, Elsa Sleiman, Javier Pinilla-Ibarz, Farrukh T. Awan, and Mohamed A. Kharfan-Dabaja, “Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?,” Blood Reviews, 2017. View at Publisher · View at Google Scholar
  • Heather Brumbaugh Paradis, Debbie Alter, and Diane Llerandi, “Venetoclax: Management and Care for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
,” Clinical Journal of Oncology Nursing, vol. 21, no. 5, pp. 604–610, 2017. View at Publisher · View at Google Scholar
  • Hadar Amir, Thomas Touboul, Karen Sabatini, Divya Chhabra, Ibon Garitaonandia, Jeanne F. Loring, Robert Morey, and Louise C. Laurent, “ Spontaneous Single-Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival ,” Stem Cells, vol. 35, no. 4, pp. 872–885, 2017. View at Publisher · View at Google Scholar
  • Faiq Shaikh, Amna Janjua, Frederick Van Gestel, and Adeel Ahmad, “Richter Transformation of Chronic Lymphocytic Leukemia: A Review of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography and Molecular Diagnostics.,” Cureus, vol. 9, no. 1, 2017. View at Publisher · View at Google Scholar
  • Helena Podgornik, Petra Bajuk, Tadej Furlan, Hermina Cibej, Ana D. Kebe, and Peter Cernelc, “CpG-ODN stimulation in population screening monoclonal B-Cell lymphocytosis,” Clinical Laboratory, vol. 63, no. 10, pp. 1723–1729, 2017. View at Publisher · View at Google Scholar
  • Cristina Bagacean, Adrian Tempescul, Anne Bordron, Victor Cristea, Pierre-François Cartron, Nathalie Douet-Guilbert, Christian Berthou, Yves Renaudineau, Christelle Le Dantec, Audrey Mohr, Hussam Saad, Valerie Olivier, and Mihnea Zdrenghea, “Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia,” Oncotarget, vol. 8, no. 39, pp. 65699–65716, 2017. View at Publisher · View at Google Scholar
  • Sotirios G. Papageorgiou, Christos K. Kontos, Marios A. Diamantopoulos, Anthi Bouchla, Eirini Glezou, Efthymia Bazani, Vasiliki Pappa, and Andreas Scorilas, “MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis,” Disease Markers, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Thomas S. K. Wan, Eleanor K. C. Hui, and Margaret H. L. Ng, “Significance of Cytogenetics in Leukemia Diagnostics,” Current Genetic Medicine Reports, 2018. View at Publisher · View at Google Scholar
  • Jess F Peterson, Daniel L Van Dyke, Nicole L Hoppman, Hutton M Kearney, William R Sukov, Patricia T Greipp, Rhett P Ketterling, and Linda B Baughn, “The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms,” American Journal of Clinical Pathology, 2018. View at Publisher · View at Google Scholar
  • Sotirios G. Papageorgiou, Christos K. Kontos, Panagiotis Tsiakanikas, Georgia Stavroulaki, Anthi Bouchla, Diamantina Vasilatou, Efthymia Bazani, Afroditi Lazarakou, Andreas Scorilas, and Vasiliki Pappa, “Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia,” Leukemia Research, vol. 70, pp. 1–7, 2018. View at Publisher · View at Google Scholar
  • Sotirios G. Papageorgiou, Marios A. Diamantopoulos, Christos K. Kontos, Anthi Bouchla, Diamantina Vasilatou, Efthymia Bazani, Andreas Scorilas, and Vasiliki Pappa, “MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia,” Leukemia & Lymphoma, pp. 1–10, 2018. View at Publisher · View at Google Scholar
  • Gueorgui Balatzenko, and Margarita Guenova, “Introductory Chapter: Hematology in Times of Precision and Innovation,” Hematology - Latest Research and Clinical Advances, 2018. View at Publisher · View at Google Scholar
  • Elaine Vickers, “Targeted Treatments for Hematological Cancers,” A Beginner's Guide to Targeted Cancer Treatments, pp. 259–312, 2018. View at Publisher · View at Google Scholar
  • Marie Rogne, Oksana Svaerd, Julia Madsen-Østerbye, Adnan Hashim, Geir E. Tjønnfjord, and Judith Staerk, “Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia,” Journal of Cellular and Molecular Medicine, 2018. View at Publisher · View at Google Scholar
  • Prabhjot Kaur, and Prabhjot Kaur, “Prognostic Indicators in CLL: Clinical, Cytogenetics, Novel Mutations, MicroRNAs, Hierarchal Classification,” Chronic Lymphocytic Leukemia, pp. 35–60, 2018. View at Publisher · View at Google Scholar
  • Prajwal Boddu, and Alessandra Ferrajoli, “Prognostic Factors in the Era of Targeted Therapies in CLL,” Current Hematologic Malignancy Reports, 2018. View at Publisher · View at Google Scholar
  • Abhinav Agrawal, Neha Gupta, Michael Esposito, Pragati Tandon, Seth Koenig, and Sameer Khanijo, “Pathologic Findings in Bronchopulmonary Leukemic Infiltrates in Patients with Chronic Lymphocytic Leukemia,” Clinical Lymphoma Myeloma and Leukemia, 2018. View at Publisher · View at Google Scholar
  • Kathy Chun, Gail D. Wenger, Alka Chaubey, D.P. Dash, Rashmi Kanagal-Shamanna, Sibel Kanturci, Ravindra Kolhe, Daniel L. Van Dyke, Lu Wang, Daynna J. Wolff, and Patricia M. Miron, “Assessing Copy Number Aberrations and Copy-Neutral Loss-of-Heterozygosity Across the Genome as Best Practice: An Evidence-Based Review from the Cancer Genomics Consortium (CGC) Working Group for Chronic Lymphocytic Leukemia,” Cancer Genetics, 2018. View at Publisher · View at Google Scholar
  • Gönül Oğur, Ömer Salih Akar, Huri Sema Aymelek, Mehmet Turgut, Engin Altundağ, Düzgün Özatlı, and Ümmet Abur, “Impact of fluorescent in situ hybridization aberrations and CLLU1 expression on the prognosis of chronic lymphocytic leukemia: Presentation of 156 patients from Turkey,” Turkish Journal of Hematology, vol. 35, no. 1, pp. 61–65, 2018. View at Publisher · View at Google Scholar